BNP Paribas Financial Markets
STLN

BNP Paribas Financial Markets’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

BNP Paribas Financial Markets’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52K Buy
16,928
+1,950
+13% +$5.98K ﹤0.01% 4675
2025
Q4 		$53.3K Buy
14,978
+2,859
+24% +$10.6K ﹤0.01% 4661
2025
Q3 		$42.3K Buy
12,119
+7,091
+141% +$24.3K ﹤0.01% 4668
2025
Q2 		$10.3K Buy
5,028
+5,023
+100,460% +$12.6K ﹤0.01% 4835
2025
Q1 		$6 Hold
5
– – ﹤0.01% 5352
2024
Q4 		$2 Buy
+5
New +$1 ﹤0.01% 5390

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets's STLN Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 13% in Q1 2026, buying an estimated $5.98K and bringing the position to 16,928 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #4675.

BNP Paribas Financial Markets first reported a position in STLN in Q4 2024 and has held it in 6 quarters since. The position peaked at $53.3K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • BNP Paribas Financial Markets held 16,928 shares of Starling Oncology Institute, Inc. Common Stock worth $52K as of Q1 2026.
  • BNP Paribas Financial Markets bought 1,950 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $5.98K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4675 holding.
  • BNP Paribas Financial Markets first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Starling Oncology Institute, Inc. Common Stock position peaked at $53.3K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.